Actively Recruiting

Phase Not Applicable
Age: 6Years - 11Years
All Genders
NCT04159168

Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Led by University of Alabama, Tuscaloosa · Updated on 2025-06-15

168

Participants Needed

1

Research Sites

284 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to test a novel intervention for children ages 6-11 with elevated callous-unemotional (CU) traits. Conduct problems are among the most prevalent and costly mental health conditions of childhood, and a common antecedent to adult psychiatric disorders. An established risk factor for early, persistent, and severe youth misconduct is the presence of CU traits. CU traits (e.g., lack of empathy or guilt, shallow affect) are analogous to the core affective features of adult psychopathy, interfere with child socialization, and predict poorer outcomes, even with well-established treatments for disruptive behavior disorders. Thus, novel intervention approaches are needed to target CU traits. Youth with elevated CU traits show deficits in facial emotion recognition (FER) for distress-related expressions, particularly fear or sadness. The central hypothesis is that impaired sensitivity for emotional distress cues (fear and/or sadness) is mechanistically linked to CU traits in children, and that, by targeting affect sensitivity directly, intervention can exert downstream effects on CU traits. A gap in the field regards how to remediate these neurocognitive deficits. This project will directly target affect sensitivity in high-CU youth. The investigators propose an experimental therapeutics approach to develop a novel neurocognitive intervention for CU traits, in which a clearly identified target, facial affect sensitivity (FAS), will be engaged and assessed via primary (distress FER accuracy and/or heightened eye gaze) and secondary (electroencephalograph event-related potential) neurocognitive and behavioral processes. If investigators can demonstrate engagement of the target (FAS) in the initial R61 phase, then in the R33 phase, this finding will be replicated with a new, larger sample, and feasibility and preliminary efficacy of FAST on CU traits will be examined. The long-term goal is to examine FAST impact on behavioral outcomes and to potentially apply this targeted intervention to the wider range of problems associated with CU traits.

CONDITIONS

Official Title

Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Who Can Participate

Age: 6Years - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • A standard score less than or equal to 8 on the NEPSY Affect Recognition test, or 70% accuracy or less for distress-related emotions on a Dynamic Facial Emotion Recognition measure
  • Composite IQ score of at least 80 on the Wechsler Abbreviated Scale of Intelligence, Second Edition
  • Psychotropic medications must be on a stable dosing schedule for at least 2 weeks before entering the study
  • Elevated callous-unemotional traits defined as a score of "2" on at least 2 of 4 CU items on the Antisocial Process Screening Device
Not Eligible

You will not qualify if you...

  • Diagnosis of bipolar disorder
  • Current risk for suicide or harm to others
  • Diagnosis of autism spectrum disorder (ASD)
  • Currently in therapy for callous-unemotional traits or facial emotion recognition deficits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Center for Youth Development and Intervention (CYDI)

Tuscaloosa, Alabama, United States, 35487

Actively Recruiting

Loading map...

Research Team

B

Bradley A White, PhD

CONTACT

S

Susan W White, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here